Autotelic Bio - Crunchbase Company Profile & Funding

Q: Who invested in Autotelic Bio?

Autotelic Bio has 12 investors including LSK Investment And Stonebridge Capital.

Q: When was the last funding round for Autotelic Bio?

Autotelic Bio closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Autotelic Bio raised to date?

Autotelic Bio has raised obfuscated.

Overview

Autotelic Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Autotelic Bio

CB Rank

108552

Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.

Founded

obfuscation

Private

Series B

Cheongju, Ch'ungch'ong-bukto, South Korea

11-50

www.autotelic.co.kr

Biotechnology

Pharmaceutical

Product Research

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

Autotelic Bio Inc.

Also Known As

오토텔릭바이오

Operating Status

Active

Company Type

For Profit

Phone Number

+82 43 233 9373

Contact Email

BD@autotelic.co.kr

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ASODE™ Platform

A system for developing ASO drugs, including sequence design, chemical modification, and in vitro/in vivo evaluation to derive optimal ASO new drugs.

CATs™ (Conjugated ASO Targeting Solution)

A technology that combines ASO with antibodies or peptides to reduce side effects and enhance efficacy.

Research & Development

Autotelic Bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Autotelic Bio	7	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
LSK Investment	—	Series B - Autotelic Bio	—
LSK Investment	—	Series B - Autotelic Bio	—
LSK Investment	—	Series B - Autotelic Bio	—
LSK Investment	—	Series B - Autotelic Bio	—
LSK Investment	—	Series B - Autotelic Bio	—